Arrayit Corporation (OTC: ARYC), a developer, manufacturer and marketer of proprietary life sciences technologies and consumables for disease prevention, treatment and cure, announces that it is well-positioned to capture a significant share in the gene testing market. The worldwide gene testing market is expected to grow significantly over the next few years. ARYC believes that through its patented microarray manufacturing platform and VIP “patent on chip” gene testing technology, it has the ability to become a gene testing market leader. The company has already signed an exclusive distribution agreement with India-based DHK Medical Products under which DHK will sell ARYC’s genomic tests in India.
To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/
About Arrayit Corporation
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.
About Liston Street Pulse
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.
###
